DEA Targets New Synthetic Drug for Schedule I Ban
Published Date: 10/2/2025
Proposed Rule
Summary
The DEA wants to officially put MDMB-4en-PINACA, a powerful drug, into Schedule I, meaning it’s illegal to make, sell, or use. This move helps the U.S. follow international drug rules and keeps strict penalties for anyone caught handling it. If approved, these rules will stay in place permanently, affecting manufacturers, researchers, and users right away.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
Possession and Handling Made Illegal
If finalized, MDMB-4en-PINACA would be placed in Schedule I. That would make it illegal to manufacture, distribute, import, export, or possess MDMB-4en-PINACA, and the existing Schedule I regulatory controls plus civil, administrative, and criminal sanctions would apply to people who handle it.
Researchers Subject to Schedule I Controls
If finalized, people who 'engage in research, conduct instructional activities or chemical analysis' with MDMB-4en-PINACA would be covered by the same Schedule I regulatory controls and civil, administrative, and criminal sanctions as other Schedule I substances.
Manufacturers and Traders Face Permanent Controls
If finalized, MDMB-4en-PINACA would be placed in Schedule I and the rule would make permanent the existing regulatory controls and civil, administrative, and criminal sanctions that apply to manufacture, distribution, importation, and export of Schedule I substances.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05482 — Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
If you order Schedule I or II drugs using DEA Form 222, this update clears up who can sign and manage the form—only registrants, their partners, or officers can do it. It also removes old rules about the old triplicate form, making things simpler and clearer. These fixes don’t change any big rules and take effect on March 20, 2026, so no extra costs or hassles ahead!
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
2026-05359 — Importer of Controlled Substances Application: United States Pharmacopeial Convention
The United States Pharmacopeial Convention wants to become an official importer of certain controlled substances like Cathinone and Methcathinone. If you’re a registered manufacturer or interested party, you have until April 20, 2026, to share your thoughts or ask for a hearing. This move could impact how these substances are imported and tracked, but no direct costs are mentioned.
Previous / Next Documents
Previous: 2025-19280 — Visibility Protection: Regional Haze State Plan Requirements Rule Revision
The EPA wants to make it easier for states to protect clear skies in special natural areas by updating the rules they follow. States that manage air quality near these spots will see changes in how they plan and report their progress. The EPA is asking for ideas now, so expect new rules and deadlines soon that could save time and money.
Next: 2025-19363 — Fishery Management Plans of St. Croix and St. Thomas and St. John; Queen Triggerfish Management Measures
Fishermen and seafood lovers around St. Croix, St. Thomas, and St. John, listen up! New rules are coming to adjust how many queen triggerfish can be caught each year to keep the fish population healthy and strong. These changes, based on fresh science, aim to stop overfishing and make sure there’s plenty of fish for the future—starting as soon as the rule is official.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in